Skip to content
Search

Latest Stories

Maxwell's hundred carries Australia to five-wicket win over India

The Aussies go past India’s 222 for 3 in the last ball of the match

Maxwell's hundred carries Australia to five-wicket win over India

Glenn Maxwell's fiery unbeaten hundred carried Australia to a five-wicket win over India in the third T20I Guwahati on Tuesday (28).

With this win, Australia managed to cut India's series lead to 2-1 in the five-match rubber.

Maxwell made 104 off 48 balls (8x4, 8x6) as the Aussies went past India's 222 for 3 in the last ball of the match.

Skipper Matthew Wade remained not out on a crucial 28 off 16 balls.

Leg-spinner Ravi Bishnoi took two wickets for India.

Earlier, India opener Ruturaj Gaikwad smashed an unbeaten 123 off 57 balls and put on 141 runs with Tilak Varma to take the attack to the opposition bowlers after the hosts lost two early wickets.

Gaikwad, who hit 58 in the team's previous win, reached his 100 off 52 balls and hammered three sixes and two fours in a 30-run final over.

Australia elected to bowl first with Travis Head returning to the team after his match-winning century in the ODI World Cup final earlier this month.

The tourists made wholesale changes to their squad as they reportedly sent home World Cup stars Steve Smith and Adam Zampa.

Marcus Stoinis, Maxwell, Josh Inglis and Sean Abbott - all part of the group that won a record-extending sixth 50-over World Cup title - are to fly home after this game.

Jason Behrendorff struck first to remove in-form Yashasvi Jaiswal caught behind for six and fellow quick Kane Richardson had Ishan Kishan out for a duck.

Captain Suryakumar Yadav fell after a 29-ball 39 to Nathan Ellis, but Gaikwad stood firm to hit back in a partnership with Varma, who hit 31.

(Agencies)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less